IOM Proposal Could Open Door For Biomarkers In Supplement Research

An Institute of Medicine report recommending a framework for assessing biomarkers for food and supplement health claims could help the supplement industry because it "will set the stage for being able to validate more biomarkers," said Andrew Shao, senior VP of scientific and regulatory affairs with the Council for Responsible Nutrition

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet